Tissue polypeptide specific antigen (TPS) throughout normal pregnancy

Anticancer Research

Volumn 20, Issue 3 B, 2000, Pages 2129-2131

  Kassanos, Demetrios ^a,b   Botsis, Demetrios ^a   Rizos, Demetrios ^a   Kontoravdis, Antonios ^a   Sikiotis, Konstantinos ^a   Phocas, Iphigenia ^a   Sarandakou, Angeliki ^a   Creatsas, George ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER;

AMNION FLUID; ARTICLE; BLOOD LEVEL; BREAST CANCER; CESAREAN SECTION; CHILDBIRTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; LABOR; MATERNAL SERUM; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; VAGINAL DELIVERY;

ADULT; AMNIOTIC FLUID; CESAREAN SECTION; DELIVERY, OBSTETRIC; FEMALE; GESTATIONAL AGE; HUMANS; PREGNANCY; PREGNANCY TRIMESTERS; REFERENCE VALUES; SURGICAL PROCEDURES, ELECTIVE; TISSUE PLASMINOGEN ACTIVATOR; TUMOR MARKERS, BIOLOGICAL;

EID: 0033877283     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Gion M, Mione R, Becciolini A, Balzi M, Correale M, Piffanelli A, Giovannini G, Saccani Jotti G, Fontanesi M: Relationship between cytosol TPS, TPA and cell proliferation. Int J Biol Markers 9: 109-114, 1994.
2. Van Dalen A, Van Der Linde DL, Heering KJ, Blusse Van Oudalhlasr A: How can response be measured in breast cancer patients? Anticancer Res 13: 1901-1904. 1993.
3. Sarandakou A, Phocas I, Botsis D, Sikiotis K, Rizos D, Kalambokis D, Trakakis E, Chryssikopoulos A: Tumor-associated antigens CEA, CA125, SCC and TPS in gynaecological cancer. Eur J Gynaec Oncol 19: 73-77, 1998.
4. Van Dalen A: How to integrate serum tumor markers into clinical oncologic practice. Nutrition 11 (5 Suppl): 889-91, 1995.
5. Lelle RJ, Henkel E, Leinemann D, Goeschen K: Measurement of CEA, TPA, Neopterin, CA125, CA153 and CA19-9 in sera of pregnant women, umbilical cord blood and amniotic fluid, gynaecol Obstet Invest 27: 137-142, 1989
6. Ng JSY, Sturgeon CM, Seth J, Paterson GM, Roulston JE, Leonard RCF: Sero-logic markers for metastatic breast cancer. Dis Markers 11: 217-223, 1993.
7. Van Dalen A: TPS monitoring in metastatic breast cancer. Int J Biol Markers 14(1): 45-8, 1994.
8. Zygmunt A, Madry R, Markowska J, Fischer Z: Estimation of the usefulness of neoplastic markers TPS and CA125 in diagnosis and monitoring of ovarian cancer. Eur J Gynaecol Oncol 20(4): 298-301, 1999.
9. Inaba N, Fukasawa I, Okajima Y, Ota Y, Tanaka K, Matsui H, Iwasaki H, Sato, N, Sudo H, Bjorklund B et al. Immunoradiometrical measurement of Tissue Polypeptide Specific Antigen (TPS), in normal, healthy, non pregnant and pregnant Japanese women. Assia-Oceania J Obstet gynaecol 19(4): 459-466, 1993
10. Bergant A, Kircher H, Schrocksnadel H, Daxenbichler G: Tissue polypeptide antigen during parturition and puerperium. Gynecol Obstet Invest 41(4): 237-39, 1996.
11. Inaba N, Fugazama I, Ota Y, Nito A, Ijichi M, Sato N, Takamizama H: Tissue polypeptide antigen and cancer antigen 125 in pregnancy.-These two cancer-related antigens arc oncofetal? Acta Obstet Gynaecol Jpn 37: 2139-2140, 1985.
12. Reblandl W, Paya K, Felberbauer FX, Fuchs R, Henkel J, Bieglmayer C, Horcher E: Tissue polypeptide-specific antigen (TPS) in pediatric malignancies. Anticancer Res 17(4B): 2865-8, 1999.
13. Itahashi K, Inaba N, Fugazawa I, and Takamizawa H: Immunoradiometrical measurement of tissue polypeptide antigen (TPA) and cancer antigen 125(CA125) in pregnancy and at delivery. Arch Gynecol Obstet 243: 191-197, 1988.
14. Sarandakou A, Giannaki G, Malamitsi-Puchner A, Rizos D, Hourdaki E, Protonotariou E and Phocas I: Inflammatory cytokines in newborn infants. Mediators of inflammation 7: 309-312, 1998.